HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).

Francesco Soria,M. Moschini,Andrea Haitel,Grégory Johann Wirth,Jose Antonio Karam,Christopher G. Wood,M. Rouprêt,Vitaly Margulis,Pierre I. Karakiewicz,Alberto Briganti,Jay D. Raman,Solène Kammerer-Jacquet,Romain Mathieu,K. Bensalah,Yair Lotan,Mehmet Özsoy,Mesut Remzi,Kilian M. Gust,Shahrokh F. Shariat

HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).

2017

Francesco Soria
M. Moschini
Andrea Haitel
Grégory Johann Wirth
Jose Antonio Karam
Christopher G. Wood
M. Rouprêt
Vitaly Margulis
Pierre I. Karakiewicz
Alberto Briganti
Jay D. Raman
Solène Kammerer-Jacquet
Romain Mathieu
K. Bensalah
Yair Lotan
Mehmet Özsoy
Mesut Remzi
Kilian M. Gust
Shahrokh F. Shariat

Purpose The aim of our study was to evaluate the expression pattern of HER2 overexpression in patients with upper tract urothelial carcinoma (UTUC) and to evaluate its association with clinical outcomes.

Keywords:

Urology
CARCINOMA TRANSITIONAL CELL
Carcinoma
Ureteral neoplasm
Pathology
Oncology
Retrospective cohort study
Internal medicine
Medicine
expression pattern
upper tract
urothelial carcinoma
in patient
urothelial cancer
Nephrology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations